Many New Cancer Drugs in the United Kingdom Are Facing Negative NICE Rulings

20079 citationsletterbronze Open Access

Authors

Abstract

susceptibility described earlier, and thus may vary over time and across populations.Studies such as that of Capalbo are an important contribution toward refining our understanding of this critical parameter.

Topics & Keywords

Health Systems, Economic Evaluations, Quality of Life Economic and Financial Impacts of Cancer Pharmaceutical Economics and Policy

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 25, Issue 18, pp. 2635-2636

DOI: 10.1200/jco.2007.11.4272

Field-Weighted Citation Impact: 3.19